Hoang Peter L. 4
4 · Marker Therapeutics, Inc. · Filed Aug 15, 2019
Insider Transaction Report
Form 4
Hoang Peter L.
DirectorCEO and President
Transactions
- Purchase
Common Stock
2019-08-14$4.62/sh+10,000$46,200→ 189,711 total
Footnotes (1)
- [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.55 to $4.67, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.